Thursday links: meaning through motion
2 days ago
2 MIN READ
Market concentration
- Market concentration is just a fact of life right now for investors. (morningstar.com)
- Concentrated market performance is tough for hedge funds. (axios.com)
Finance
- How Navan ($NAVN) went public in a government shutdown. (semafor.com)
- Beignet, think Meta and Blue Owl, ‘represents by far the single largest individual high-grade bond ever issued.’ (giftarticle.ft.com)
AI
- Investors should be skeptical when this much capital is being spent pursuing an opportunity. (morningstar.com)
- Google ($GOOGL) and Microsoft ($MSFT) have committed unprecedented sums to capex. (tomtunguz.com)
Work
- When calling a job candidate ‘overqualified’ is cover for age discrimination. (wsj.com)
- On the AI career ‘vibes gap.’ (agglomerations.substack.com)
Weight loss
- Tirzepatide, sold as Zepbound for obesity and Mounjaro for diabetes, is now the best selling drug in the world. (biopharmadive.com)
- There is now a bidding war for obesity drug maker Metsera ($MTSR). (wsj.com)
- Eli Lilly ($LLY) is teaming with Walmart ($WMT) to expand access to Zepbound. (biopharmadive.com)
- Inside the race to get an oral GLP-1 agonist to market. (giftarticle.ft.com)
- The obesity rate in the U.S. is falling due to GLP-1 agonist use. (npr.org)
China
- Please do not sell B30A chips to China. (thezvi.substack.com)
- Eric Schmidt and Selina Xu, “The Chinese government seems to recognize the power of open-source AI.” (theatlantic.com)
- China won the ‘trade war.’ (paulkrugman.substack.com)
Health care
- In-home care prices are rising a much higher rate than inflation. (axios.com)
- People are getting a preview of ACA premium increases for 2026. (axios.com)
Earlier on Abnormal Returns
- Longform links: doing meaningful work. (abnormalreturns.com)
- What you missed in our Wednesday linkfest. (abnormalreturns.com)
- Personal finance links: paying for advice. (abnormalreturns.com)
- Don’t miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
Mixed media
Terms and Conditions
This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.
The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.
References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.
Please see disclosures here.